HEADER TRANSFERASE 07-JAN-10 3LAU TITLE CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 125-399; COMPND 5 SYNONYM: AURORA KINASE A, AURORA-A, SERINE/THREONINE KINASE 15, COMPND 6 AURORA/IPL1-RELATED KINASE 1, AURORA-RELATED KINASE 1, HARK1, BREAST COMPND 7 TUMOR-AMPLIFIED KINASE; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AIK, ARK1, AURA, AURKA, BTAK, STK15, STK6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE INHIBITOR COMPLEX, ATP-BINDING, CELL CYCLE, CYTOPLASM, KEYWDS 2 CYTOSKELETON, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, KEYWDS 3 POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, UBL KEYWDS 4 CONJUGATION EXPDTA X-RAY DIFFRACTION AUTHOR S.MAIGNAN,J.P.GUILLOTEAU,S.POUZIEUX REVDAT 5 06-SEP-23 3LAU 1 REMARK REVDAT 4 13-OCT-21 3LAU 1 REMARK SEQADV REVDAT 3 24-JAN-18 3LAU 1 AUTHOR REMARK REVDAT 2 07-APR-10 3LAU 1 JRNL REVDAT 1 02-MAR-10 3LAU 0 JRNL AUTH D.LESUISSE,G.DUTRUC-ROSSET,G.TIRABOSCHI,M.K.DREYER, JRNL AUTH 2 S.MAIGNAN,A.CHEVALIER,F.HALLEY,P.BERTRAND,M.C.BURGEVIN, JRNL AUTH 3 D.QUARTERONET,T.ROONEY JRNL TITL RATIONAL DESIGN OF POTENT GSK3BETA INHIBITORS WITH JRNL TITL 2 SELECTIVITY FOR CDK1 AND CDK2. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 1985 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20167481 JRNL DOI 10.1016/J.BMCL.2010.01.114 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 638 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2072 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 CRYSTAL PACKING INTERACTIONS INDUCE A REARRANGEMENT REMARK 3 OF SOME ACTIVATION LOOP RESIDUES (ARG255-HIS257) REMARK 3 CLOSE TO THE BINDING SITE. THIS IS NOT OBSERVED IN REMARK 3 OTHER CRYSTAL FORM AND CAN HAVE SOME IMPACT ON REMARK 3 LIGAND BINDING. REMARK 4 REMARK 4 3LAU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1000057049. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : DIAMONDS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13872 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06100 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1MQ4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000 26% - TRIS 100MM PH 8.5 - DTT REMARK 280 5MM - MGCL2 1MM - NAACETATE 200MM, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.80850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 276 REMARK 465 TRP A 277 REMARK 465 SER A 278 REMARK 465 VAL A 279 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 ASP A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 GLY A 291 REMARK 465 THR A 292 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 ALA A 400 REMARK 465 ALA A 401 REMARK 465 ALA A 402 REMARK 465 LEU A 403 REMARK 465 GLU A 404 REMARK 465 HIS A 405 REMARK 465 HIS A 406 REMARK 465 HIS A 407 REMARK 465 HIS A 408 REMARK 465 HIS A 409 REMARK 465 HIS A 410 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MET A 124 CG SD CE REMARK 480 GLU A 131 CD OE1 OE2 REMARK 480 LYS A 141 CG CD CE NZ REMARK 480 LYS A 143 CB CG CD CE NZ REMARK 480 GLN A 154 CG CD OE1 NE2 REMARK 480 GLU A 170 CD OE1 OE2 REMARK 480 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 480 ARG A 180 CD NE CZ NH1 NH2 REMARK 480 GLU A 181 CG CD OE1 OE2 REMARK 480 GLU A 183 CG CD OE1 OE2 REMARK 480 ARG A 189 NE CZ NH1 NH2 REMARK 480 ARG A 220 NE CZ NH1 NH2 REMARK 480 LYS A 258 CG CD CE NZ REMARK 480 TYR A 334 CG CD1 CD2 CE1 CE2 CZ REMARK 480 TYR A 338 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 LYS A 339 CD CE NZ REMARK 480 ASP A 350 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 6 O HOH A 17 2.15 REMARK 500 ND1 HIS A 254 O HOH A 9 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 25 O HOH A 29 2656 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 274 C PHE A 275 N 0.140 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 275 N - CA - CB ANGL. DEV. = -24.8 DEGREES REMARK 500 PHE A 275 CB - CG - CD2 ANGL. DEV. = 11.0 DEGREES REMARK 500 PHE A 275 CB - CG - CD1 ANGL. DEV. = -15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 154 -76.61 -70.06 REMARK 500 SER A 226 -35.82 82.99 REMARK 500 HIS A 254 64.76 60.88 REMARK 500 ILE A 257 32.50 -98.14 REMARK 500 ASP A 307 -153.41 -138.46 REMARK 500 LEU A 364 47.16 -94.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 PHE A 275 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OFI A 1 DBREF 3LAU A 125 399 UNP O14965 STK6_HUMAN 125 399 SEQADV 3LAU MET A 124 UNP O14965 EXPRESSION TAG SEQADV 3LAU ASP A 288 UNP O14965 THR 288 ENGINEERED MUTATION SEQADV 3LAU ALA A 400 UNP O14965 EXPRESSION TAG SEQADV 3LAU ALA A 401 UNP O14965 EXPRESSION TAG SEQADV 3LAU ALA A 402 UNP O14965 EXPRESSION TAG SEQADV 3LAU LEU A 403 UNP O14965 EXPRESSION TAG SEQADV 3LAU GLU A 404 UNP O14965 EXPRESSION TAG SEQADV 3LAU HIS A 405 UNP O14965 EXPRESSION TAG SEQADV 3LAU HIS A 406 UNP O14965 EXPRESSION TAG SEQADV 3LAU HIS A 407 UNP O14965 EXPRESSION TAG SEQADV 3LAU HIS A 408 UNP O14965 EXPRESSION TAG SEQADV 3LAU HIS A 409 UNP O14965 EXPRESSION TAG SEQADV 3LAU HIS A 410 UNP O14965 EXPRESSION TAG SEQRES 1 A 287 MET LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 A 287 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 A 287 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 A 287 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 A 287 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 A 287 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 A 287 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 A 287 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 A 287 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 A 287 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 A 287 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 A 287 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 A 287 HIS ALA PRO SER SER ARG ARG THR ASP LEU CYS GLY THR SEQRES 14 A 287 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 A 287 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 A 287 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 A 287 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 A 287 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 A 287 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 A 287 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 A 287 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 22 A 287 GLU SER ALA ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS SEQRES 23 A 287 HIS HET OFI A 1 22 HETNAM OFI N-[6-(4-HYDROXYPHENYL)-1H-INDAZOL-3-YL]BUTANAMIDE FORMUL 2 OFI C17 H17 N3 O2 FORMUL 3 HOH *92(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 VAL A 174 LEU A 188 1 15 HELIX 4 4 VAL A 218 SER A 226 1 9 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 PRO A 297 GLU A 302 1 6 HELIX 8 8 LYS A 309 GLY A 325 1 17 HELIX 9 9 THR A 333 ARG A 343 1 11 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 GLU A 379 1 7 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 A 5 PHE A 133 LYS A 141 0 SHEET 2 A 5 GLY A 145 GLU A 152 -1 O LEU A 149 N GLY A 136 SHEET 3 A 5 ILE A 158 PHE A 165 -1 O LEU A 161 N TYR A 148 SHEET 4 A 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 A 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 B 3 GLY A 216 THR A 217 0 SHEET 2 B 3 LEU A 262 LEU A 264 -1 O LEU A 264 N GLY A 216 SHEET 3 B 3 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SITE 1 AC1 11 HOH A 90 LEU A 139 VAL A 147 ALA A 160 SITE 2 AC1 11 LYS A 162 GLU A 211 TYR A 212 ALA A 213 SITE 3 AC1 11 PRO A 214 LEU A 263 PHE A 275 CRYST1 48.070 45.617 59.561 90.00 97.65 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020803 0.000000 0.002794 0.00000 SCALE2 0.000000 0.021922 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016940 0.00000